TTK and head and neck cancer: In HNSCC samples with lymphovascular invasion, the MPS1 gene expression was shown to be upregulated when compared to normal samples, and samples with high expression of MPS1 were associated with worse prognosis [224], highlighting the potential of MPS1 targeting for head and neck cancer.